Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Hemlibra PI 27 May 2022
Hemlibra CMI 27 May 2022
Xalamol 50/5 PI 27 May 2022
Xalamol 50/5 CMI 27 May 2022
Tamiflu CMI 27 May 2022

New products

Product name Type Date released
Xospata PI 27 May 2022
Ovaleap PI 23 May 2022
Ovaleap CMI 23 May 2022
Zestril CMI 10 May 2022
Zestril PI 10 May 2022